Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 82

1.

Autologous Chondrocyte Implantation for Bipolar Chondral Lesions in the Tibiofemoral Compartment.

Ogura T, Bryant T, Mosier BA, Minas T.

Am J Sports Med. 2018 May;46(6):1371-1381. doi: 10.1177/0363546518756977. Epub 2018 Mar 13.

PMID:
29533678
2.

Optimization of Extracellular Matrix Synthesis and Accumulation by Human Articular Chondrocytes in 3-Dimensional Construct with Repetitive Hydrostatic Pressure.

Ogura T, Tsuchiya A, Minas T, Mizuno S.

Cartilage. 2018 Apr;9(2):192-201. doi: 10.1177/1947603517743546. Epub 2017 Dec 21.

PMID:
29262701
3.

ADHFE1 is a breast cancer oncogene and induces metabolic reprogramming.

Mishra P, Tang W, Putluri V, Dorsey TH, Jin F, Wang F, Zhu D, Amable L, Deng T, Zhang S, Killian JK, Wang Y, Minas TZ, Yfantis HG, Lee DH, Sreekumar A, Bustin M, Liu W, Putluri N, Ambs S.

J Clin Invest. 2018 Jan 2;128(1):323-340. doi: 10.1172/JCI93815. Epub 2017 Nov 27.

4.

Analysis of Tumor Biology to Advance Cancer Health Disparity Research.

Smith CJ, Minas TZ, Ambs S.

Am J Pathol. 2018 Feb;188(2):304-316. doi: 10.1016/j.ajpath.2017.06.019. Epub 2017 Nov 11. Review.

PMID:
29137948
5.

Autologous Chondrocyte Implantation "Sandwich" Technique Compared With Autologous Bone Grafting for Deep Osteochondral Lesions in the Knee.

Minas T, Ogura T, Headrick J, Bryant T.

Am J Sports Med. 2018 Feb;46(2):322-332. doi: 10.1177/0363546517738000. Epub 2017 Nov 10.

PMID:
29125919
6.

A 20-Year Follow-up After First-Generation Autologous Chondrocyte Implantation.

Ogura T, Mosier BA, Bryant T, Minas T.

Am J Sports Med. 2017 Oct;45(12):2751-2761. doi: 10.1177/0363546517716631. Epub 2017 Jul 26.

PMID:
28745972
7.

Inhibition of ERG Activity in Patient-derived Prostate Cancer Xenografts by YK-4-279.

Winters B, Brown L, Coleman I, Nguyen H, Minas TZ, Kollath L, Vasioukhin V, Nelson P, Corey E, Üren A, Morrissey C.

Anticancer Res. 2017 Jul;37(7):3385-3396.

PMID:
28668826
8.

Autologous Chondrocyte Implantation to Isolated Patella Cartilage Defects.

von Keudell A, Han R, Bryant T, Minas T.

Cartilage. 2017 Apr;8(2):146-154. doi: 10.1177/1947603516654944. Epub 2016 Jul 8.

9.

Intralesional Osteophyte Regrowth Following Autologous Chondrocyte Implantation after Previous Treatment with Marrow Stimulation Technique.

Demange MK, Minas T, von Keudell A, Sodha S, Bryant T, Gomoll AH.

Cartilage. 2017 Apr;8(2):131-138. doi: 10.1177/1947603516653208. Epub 2016 Jul 7.

10.

Intermediate- to Long-Term Results of Combined Anterior Cruciate Ligament Reconstruction and Autologous Chondrocyte Implantation.

Pike AN, Bryant T, Ogura T, Minas T.

Orthop J Sports Med. 2017 Feb 24;5(2):2325967117693591. doi: 10.1177/2325967117693591. eCollection 2017 Feb.

11.

Long-term Outcomes of Autologous Chondrocyte Implantation in Adolescent Patients.

Ogura T, Bryant T, Minas T.

Am J Sports Med. 2017 Apr;45(5):1066-1074. doi: 10.1177/0363546516682492. Epub 2017 Jan 27.

PMID:
28129512
12.
13.

Depletion of tyrosyl DNA phosphodiesterase 2 activity enhances etoposide-mediated double-strand break formation and cell killing.

Kont YS, Dutta A, Mallisetty A, Mathew J, Minas T, Kraus C, Dhopeshwarkar P, Kallakury B, Mitra S, Üren A, Adhikari S.

DNA Repair (Amst). 2016 Jul;43:38-47. doi: 10.1016/j.dnarep.2016.04.009. Epub 2016 May 7.

PMID:
27235629
14.

Combined experience of six independent laboratories attempting to create an Ewing sarcoma mouse model.

Minas TZ, Surdez D, Javaheri T, Tanaka M, Howarth M, Kang HJ, Han J, Han ZY, Sax B, Kream BE, Hong SH, Çelik H, Tirode F, Tuckermann J, Toretsky JA, Kenner L, Kovar H, Lee S, Sweet-Cordero EA, Nakamura T, Moriggl R, Delattre O, Üren A.

Oncotarget. 2017 May 23;8(21):34141-34163. doi: 10.18632/oncotarget.9388.

15.

Ezrin Inhibition Up-regulates Stress Response Gene Expression.

Çelik H, Bulut G, Han J, Graham GT, Minas TZ, Conn EJ, Hong SH, Pauly GT, Hayran M, Li X, Özdemirli M, Ayhan A, Rudek MA, Toretsky JA, Üren A.

J Biol Chem. 2016 Jun 17;291(25):13257-70. doi: 10.1074/jbc.M116.718189. Epub 2016 May 2.

16.

Ezrin Enhances EGFR Signaling and Modulates Erlotinib Sensitivity in Non-Small Cell Lung Cancer Cells.

Saygideğer-Kont Y, Minas TZ, Jones H, Hour S, Çelik H, Temel I, Han J, Atabey N, Erkizan HV, Toretsky JA, Üren A.

Neoplasia. 2016 Feb;18(2):111-20. doi: 10.1016/j.neo.2016.01.002.

17.

Methods of high integrity RNA extraction from cell/agarose construct.

Ogura T, Tsuchiya A, Minas T, Mizuno S.

BMC Res Notes. 2015 Nov 4;8:644. doi: 10.1186/s13104-015-1627-5.

18.

YK-4-279 effectively antagonizes EWS-FLI1 induced leukemia in a transgenic mouse model.

Minas TZ, Han J, Javaheri T, Hong SH, Schlederer M, Saygideğer-Kont Y, Çelik H, Mueller KM, Temel I, Özdemirli M, Kovar H, Erkizan HV, Toretsky J, Kenner L, Moriggl R, Üren A.

Oncotarget. 2015 Nov 10;6(35):37678-94. doi: 10.18632/oncotarget.5520.

19.

Identification of Novel Ezrin Inhibitors Targeting Metastatic Osteosarcoma by Screening Open Access Malaria Box.

Çelik H, Hong SH, Colón-López DD, Han J, Kont YS, Minas TZ, Swift M, Paige M, Glasgow E, Toretsky JA, Bosch J, Üren A.

Mol Cancer Ther. 2015 Nov;14(11):2497-507. doi: 10.1158/1535-7163.MCT-15-0511. Epub 2015 Sep 10.

20.

Ezrin Binds to DEAD-Box RNA Helicase DDX3 and Regulates Its Function and Protein Level.

Çelik H, Sajwan KP, Selvanathan SP, Marsh BJ, Pai AV, Kont YS, Han J, Minas TZ, Rahim S, Erkizan HV, Toretsky JA, Üren A.

Mol Cell Biol. 2015 Sep;35(18):3145-62. doi: 10.1128/MCB.00332-15. Epub 2015 Jul 6.

Supplemental Content

Support Center